A detailed history of Stonepine Capital Management, LLC transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 238,222 shares of ANIK stock, worth $4.25 Million. This represents 3.17% of its overall portfolio holdings.

Number of Shares
238,222
Previous 189,308 25.84%
Holding current value
$4.25 Million
Previous $4.68 Billion 16.14%
% of portfolio
3.17%
Previous 2.95%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$16.04 - $25.53 $784,580 - $1.25 Million
48,914 Added 25.84%
238,222 $3.92 Billion
Q3 2024

Nov 13, 2024

BUY
$24.25 - $28.75 $579,841 - $687,441
23,911 Added 14.46%
189,308 $4.68 Billion
Q2 2024

Aug 13, 2024

BUY
$24.57 - $28.47 $2.57 Million - $2.97 Million
104,448 Added 171.37%
165,397 $4.19 Billion
Q1 2024

May 14, 2024

BUY
$21.95 - $26.42 $1.34 Million - $1.61 Million
60,949 New
60,949 $1.55 Billion

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $260M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.